Clinical Liver Disease
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 111:15:50
- Mais informações
Informações:
Sinopse
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episódios
-
![Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases]()
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
07/06/2019 Duração: 09minAudible Article by Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, and Julie K. Heimbach
-
![Locoregional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy]()
Locoregional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy
07/06/2019 Duração: 09minAudible Article by Laura Kulik
-
![What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?]()
What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?
07/06/2019 Duração: 09minAudible Article by Neil Mehta and Francis Y. Yao
-
![Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future]()
Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future
07/06/2019 Duração: 09minAudible Article by Alisa Likhitsup, Nataliya Razumilava, and Neehar D. Parikh
-
![Hepatocellular Carcinoma Risk After Direct‐Acting Antiviral Therapy]()
Hepatocellular Carcinoma Risk After Direct‐Acting Antiviral Therapy
07/06/2019 Duração: 09minAudible Article by Feng Su and George N. Ioannou
-
![Surveillance and Diagnosis of Hepatocellular Carcinoma]()
Surveillance and Diagnosis of Hepatocellular Carcinoma
07/06/2019 Duração: 09minAudible Article by Jane Lim and Amit G. Singal
-
![Endoscopic Sedation of the Patient With Cirrhosis]()
Endoscopic Sedation of the Patient With Cirrhosis
07/06/2019 Duração: 09minAudible Article by Jerome C. Edelson and Don C. Rockey
-
![Return to Alcohol Use After Liver Transplant: Patterns and Surveillance]()
Return to Alcohol Use After Liver Transplant: Patterns and Surveillance
07/06/2019 Duração: 09minAudible Article by Brian P. Lee and Norah A. Terrault
-
![Misconceptions Surrounding Hepatocellular Carcinoma]()
Misconceptions Surrounding Hepatocellular Carcinoma
07/06/2019 Duração: 09minAudible Article by Nayantara Orekondy and Sheila Eswaran
-
![PRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission]()
PRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission
07/06/2019 Duração: 09minAudible Article by Thomas G. Cotter, Matthew W. Stier, and Andrew Aronsohn
-
![CON: Needle Exchange Programs Should Not Be Instituted to Reduce Hepatitis C Virus Transmission]()
CON: Needle Exchange Programs Should Not Be Instituted to Reduce Hepatitis C Virus Transmission
07/06/2019 Duração: 09minAudible Article by Ken O’Riordan, Mohsen Khan, and Andrew Mazulis
-
![Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?]()
Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?
07/06/2019 Duração: 09minAudible Article by Alexander Dao and Amol S. Rangnekar
-
![AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C]()
AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
07/06/2019 Duração: 09minAudible Article by Ray Chung
-
![Hepatitis C Virus in the Modern Direct‐Acting Antiviral Era: Where Have All the Special Populations Gone?]()
Hepatitis C Virus in the Modern Direct‐Acting Antiviral Era: Where Have All the Special Populations Gone?
07/06/2019 Duração: 09minAudible Article by Christian B. Ramers and Stacey B. Trooskin
-
![Epidemiology of Hepatitis C]()
Epidemiology of Hepatitis C
07/06/2019 Duração: 09minAudible Article by Syed‐Mohammed Jafri and Stuart C. Gordon
-
![Hepatitis C Virus Standard of Care: A Rapid Evolution and Considerations for Acute Hepatitis C Virus]()
Hepatitis C Virus Standard of Care: A Rapid Evolution and Considerations for Acute Hepatitis C Virus
07/06/2019 Duração: 09minAudible Article by Tram T. Tran
-
![Hepatitis C Virus Diagnostics: The Road to Simplification]()
Hepatitis C Virus Diagnostics: The Road to Simplification
07/06/2019 Duração: 09minAudible Article by Jordan J. Feld
-
![Hepatitis C Vaccine Development in the Era of Direct‐Acting Antivirals]()
Hepatitis C Vaccine Development in the Era of Direct‐Acting Antivirals
07/06/2019 Duração: 09minAudible Article by Matthew McConnell and Joseph K. Lim
-
![PRO: Patients With Hepatitis C Virus With Pretreatment Metavir Stage 3 Fibrosis Do Not Require Hepatocellular Carcinoma Surveillance After Sustained Virological Response]()
PRO: Patients With Hepatitis C Virus With Pretreatment Metavir Stage 3 Fibrosis Do Not Require Hepatocellular Carcinoma Surveillance After Sustained Virological Response
07/06/2019 Duração: 09minAudible Article by Amoah Yeboah‐Korang, Nicole M. Gentile, and Claus J. Fimmel
-
![All Patients With Advanced Fibrosis Should Continue to Be Screened for Hepatocellular Carcinoma After Sustained Virological Response of Hepatitis C Virus]()
All Patients With Advanced Fibrosis Should Continue to Be Screened for Hepatocellular Carcinoma After Sustained Virological Response of Hepatitis C Virus
07/06/2019 Duração: 09minAudible Article by Ruben Khan, Sugir Velpari, and Sean Koppe
